Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 12:44 AM
Ignite Modification Date:
2025-12-25 @ 10:56 PM
NCT ID:
NCT04285567
Group ID:
EG000
Title:
Arm A: VEN+G
Description:
Participants received obinutuzumab, 1000 mg, as IV infusion on Days 1 (and 2), 8, and 15 of Cycle 1 and Day 1 of Cycles 2-6. Participants also received venetoclax, with a 5-week ramp-up period (20 mg \[Cycle 1 Days 22-28\], 50 mg \[Cycle 2 Days 1-7\], 100 mg \[Cycle 2 Days 8-14\], 200 mg \[Cycle 2 Days 15-21\], 400 mg \[Cycle 2 Days 22-28\]) administered orally, QD. After the 5-week ramp-up period, participants received venetoclax, 400 mg, orally, QD from Cycle 3 Day 1 until the end of Cycle 12. (1 cycle = 28 days).
Deaths Number Affected:
3
Deaths Number At Risk:
None
Serious Number Affected:
47
Serious Number At Risk:
77
Other Number Affected:
76
Other Number At Risk:
77
Study:
NCT04285567
Results Section:
NCT04285567
Adverse Events Module:
NCT04285567